S4 preliminary by using double-distilled water with the final interference concentration. The fluorescence spectra
were measured with excitation wavelength at 670 nm.
Cell Culture and Imaging. HepG2 cells were maintained in RPMI-1640 medium with 10% fetal bovine serum (FBS, GIBCO) and 1% penicillin-streptomycin at 37 °C in a humidified atmosphere containing 20% O 2 and 5% CO 2 . When the cell density reached 90% of confluence, a subculture was performed and the medium was changed approximately every day. Cells were seeded in a 20 mm glass-bottom dish plated and grown to around 80% confluency for 24 h before the experiment. Fluorescence imaging of cells was carried out using an Olympus FV1000 MPE laser scanning microscope (Japan) with a 60× oil immersion objective lens. The fluorescence signal of cells incubated with NML was collected in the channel (650-750 nm) by using a semiconductor laser at 635 nm as the excitation source. The fluorescent images of mice and serum were obtained via an IVIS Lumina XR Imaging System (Caliper, U.S.A.) equipped with a cooled charge coupled device (CCD) camera with the collected channel (Cy 5.5: λ ex = 640 nm, λ em = 695−770 nm). Circular ROIs were drawn over the areas and quantified by Lumina XR Living Image software, version 4.3.
Cytotoxicity Assay. Cytotoxicity assays were carried out using HepG2 cells. Cell viability was determined using the CCK-8 assay. 5000 cells per well were seeded in a 96-well plate and incubated for 12 h in a humidified incubator for adherence. NML were dissolved in DMSO, and the solution was then added to cells at the final concentration of 0, 2, 4, 6, 8, 10, 15, 20 μM and incubated for 24 h. CCK-8 reagent diluted by RPMI-1640 (FBS free) medium (10%) was added to each well after the removal of culture media and incubated for 0.5 h. Following that, the absorbance was measured at 450 nm on a plate reader Synergy 2 Multi-Mode Microplate Reader (Bio-Tek, Winooski, VT).
HepG2 Tumor Model. All animal procedures were performed in accordance with the Guidelines for Care and Use of Laboratory Animals of Hunan University and experiments were approved by the Animal Ethics Committee of College of Biology (Hunan University). About 10 6 HepG2 cells were grafted into a nude BALB/C mouse.
Tumors with diameters of around 10 mm were formed after 20 and 30 days, respectively.
Fluorescence imaging of acetaminophen (APAP) induced liver injury in BALB/c. 30 female BALB/c (18-20 g) mice were divided into 6 groups on average; group 1: intraperitoneal injected PBS + intravenous injection NML, group 2: intraperitoneal injected APAP + intravenous injection NML, group 3: intraperitoneal injected with PBS + intravenous injected with NM, group 4: intraperitoneal injected with APAP + intravenous injected with NM, group 5: intraperitoneal injected with PBS + intravenous injected with NL, group 6: intraperitoneal injected with APAP + intravenous injected with NL. Mice were intraperitoneal injected with 100 µL of 200 mg/kg S5 acetaminophen (APAP) or 100 µL PBS for 1h, then intravenous injected with 50 µL of 100 µM NM, NL, or NML for 40 min, 80 min and 120 min. Subsequently, the mice were immediately imaged via an IVIS Lumina XR Imaging System. Circular ROIs were drawn over each well, and fluorescent intensity was quantified by Living Image software.
Construction of acetaminophen (APAP) induced liver injury (DILI) models in KM mice. 25 female KM (18-20 g) mice were divided into 5 groups on average; group 1: APAP 0 h (control), group 2: APAP 3 h, group 3: APAP 6 h, group 4: APAP 9 h, group 5: APAP 12 h. Mice were intraperitoneal injected with 200 µL of 200 mg/kg acetaminophen (APAP). For the control group, the mice were administered an intraperitoneal injection of PBS buffer (200 μL). Then, the mice were sacrificed after different administration times, then the blood and liver tissues were collected. The liver tissues were excised for histological examination by standard H&E staining. The blood was left at room temperature for 30 min and centrifuged for 10 minutes under 3000 rpm to take serum. The serum was stored in a -80°C refrigerator before testing. In both methods, serum samples were 10-fold diluted for in vitro measurement.
Construction of tetrachloromethane (CCl 4 ) induced liver cirrhosis models in KM mice. 42 female KM (18-20 g) mice were divided into 6 groups on average; group 1: CCl 4 -0 day (control), group 2: CCl 4 -8 days, group 3: CCl 4 -16 days, group 4: CCl 4 -24 days, group 5: CCl 4 -32 days, group 6: CCl 4 -40 days. Mice were subcutaneously injected with 50 µL 40% concentration of CCl 4 diluted with cotton seed oil for 40 days. In the meantime, the mice were maintained with 30% ethanol in water as drinking water. The mice were sacrificed after different administration days, then the blood was collected. The liver tissues were excised for histological examination by standard H&E staining. The blood was left at room temperature for 30 min and centrifuged for 10 minutes under 3000 rpm to take serum. The serum was stored in a -80°C refrigerator before testing. In both methods, serum samples were 10-fold diluted for in vitro measurement.
General Procedure for in vitro serum testing. The samples were 10-fold diluted for in vitro measurement.
Briefly, a volume of 10 μL of NML, NM, or NL stock solution (200 μM), 10 μL diluted serum, PBS buffer solution (180 µL) were added into the wells of 96-well flat-bottom black plate to make the final volume 200 μL, and then incubated with at 37 °C for 2 h (for NL, the incubated time is 30 min). Subsequently, the black plate was immediately measured via an IVIS Lumina XR Imaging System. Circular ROIs were drawn over each well, and fluorescent intensity was quantified by Living Image software.
Procedure for Determining LAP with Commercial Assay Kit. In this kit, the detection mechanism of LAP is based on LAP hydrolysis of L-leucyl p-nitroaniline to p-nitroaniline, which has a maximum absorption peak at 405 S6 nm, and the LAP activity is calculated by measuring the rate of increase in absorbance at 405 nm. In brief, 50 μL of the serum samples were added to a quartz cuvette, and the final volumes of the samples were adjusted to 200 μL with the LAP assay buffer containing L-leucyl p-nitroaniline. Immediately after mixing, record the initial absorbance at 405 nm (A1) and absorbance (A2) were recorded after 2 min and calculated as ΔA = A2-A1. Finally, LAP activity was calculated based on the given equation in the manufacturer's instructions: LAP (nmol/min/mL) = [ΔA × V 1 ÷ (ε × d) × 10 9 ] ÷ V 2 ÷ T = 205.8 × ΔA. V 1 : the total volume of the reaction system (200 μL), V 2 : the volume of serum (50 μL), ε: molar extinction coefficient of p-nitroaniline (9.72×10 3 L/mol/cm), d: the diameter of the cuvette (1 cm), T: reaction time (2 min).
Procedure for Determining MAO with Commercial Assay Kit. In this kit, the mechanism of MAO activity determination is based on MAO catalyzed deamination of monoamine substrate to form corresponding aldehyde, which is further oxidized to acid. The substrate has a characteristic absorption peak at 242 nm, and the MAO activity is calculated by measuring the rate of increase in absorbance at 242 nm. In brief, 20 μL of the serum samples were added to a quartz cuvette, then added MAO assay regent 1 (300 μL) and 2 (3 mL), followed by incubation at 37 °C for 3 h and then added assay regent 3 (300 μL) and 4 (3 mL), mixed and centrifuged for 10 minutes (3500 rpm), absorbance (A) at 242 nm was recorded. Finally, the MAO activity was calculated based on the given equation following the manufacturer's instructions: MAO (nmol/h/mL) = (A-A 0 )/0.01/T/V=1666.7 × ΔA.
A: absorbance of serum sample at 242 nm, A 0 : absorbance of water sample at 242 nm, T: reaction time (3 h), V:
the volume of serum (20 μL). 
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Compound Synthesis
Synthesis of Compound 2.
Compound 1 (2.79 g, 10 mmol) was dissolved in TFA/CH 2 Cl 2 (20 mL/20 mL) at room temperature for 30 min. The solvent was removed by evaporation under reduced pressure, and the obtained crude product 2 was directly used in the following reaction without further purification.
Synthesis of Compound 3.
Compound 2 (1.79 g, 10 mmol), (tert-butoxycarbonyl) leucine (2.31 g, 10 mmol), S8 EDCI (1.55 g, 10 mmol), DMAP (1.22 g, 10 mmol), HOBt (1.35 g, 10 mmol), DIPEA (3.87 g, 30 mmol) were dissolved in CH 2 Cl 2 (50 mL) at room temperature for 10 h. Then the solution was washed with water and brine, dried with anhydrous Na 2 SO 4 . The solvent was removed under reduced pressure and the residue was purified by flash chromatography column using petroleum ether/ ethyl acetate (2/1) as eluent to give compound 3 as a white solid (2.45 g, yield 62.5 %). 1 80, 172.89, 163.74, 155.84, 131.99, 130.02, 114.74, 80.09, 66.21, 53.22, 41.23, 36.74, 28.98, 28.29, 24.77, 22.93, 21.96 .
Synthesis of Compound 4.
To a suspension of compound 3 (1.18 g, 3.0 mmol) in CH 3 OH (80 mL) at 0 °C, NaBH 4 (228 mg, 6 mmol) was added slowly. After 30 min, the resulting suspension was stirred for 2 h at room temperature. Then the mixture was diluted with dichloromethane (100 mL), and washed with water and brine. The organic layer was separated and dried over anhydrous Na 2 SO 4 . The solvent was removed by evaporation under reduced pressure, and the residue was subjected to silica gel chromatography with petroleum ether/ ethyl acetate (1/1) as eluent, obtaining compound 4 as a white solid (1.00 g, yield 85%). 1 173. 00, 157.89, 155.77, 134.96, 128.32, 114.47, 78.35, 65.65, 63.01, 53.31, 41.35, 35.98, 29.32, 28.64, 24.76, 23.36, 22 .09.
Synthesis of Compound 5.
To a solution of compound 4 (985 mg, 2.5 mmol) in CH 2 Cl 2 (50 mL) at 0 °C, tribromophosphine (0.474 mL, 5.0 mmol) was added dropwise. The resulting reaction mixture was warmed up to room temperature and stirred for 5 h. Then, the mixture was diluted with dichloromethane (20 mL), and washed with water and brine. The organic layer was separated and dried with anhydrous Na 2 SO 4 . The solvent was removed by evaporation under reduced pressure, and the obtained crude product 5 was directly used in the following reaction without further purification.
Synthesis of Compound 6. 4-Bromoresorcinol (1.88 g, 10 mmol) and Et 3 N (2 mL) were placed in a flask containing DMF (10 mL), and the mixture was stirred at 50 ℃ under nitrogen atmosphere for 10 min. Compound 1 (3.0 g, 5 mmol) in DMF (10.0 mL) was introduced to the mixture via a syringe, and the reaction mixture was heated at 55 °C for 6 h. Then, the reaction solution was poured into ice water and extracted with CH 2 Cl 2 . The combined organic solution was concentrated under reduced pressure. After purified by the silica gel S9 chromatography (CH 2 Cl 2 /EtOH, 10:1, v/v), compound 6 was obtained as a blue-green solid (2.24g, 38% 11, 172.82, 160.71, 158.73, 157.66, 153.35, 145.82, 142.13, 141.59, 131.53, 130.83, 129.33, 129.12, 128.56, 127.64 (s, 4H), 122.60, 116.48, 115.25, 114.53, 112.86, 109.45, 105.15, 101.57, 77.32, 71.78, 66.18, 53.51, 50.90, 37.09, 34.87, 29.27, 29.02, 28.06, 24.77, 23.02, 21.93, 20.16 .
Synthesis of NML.
To a solution of compound 7 (100 mg, 0.12 mmol) in CH 2 Cl 2 (2 mL) at 0 °C, a dioxanehydrochloride solution (1 mL, 4 mol/L) was added dropwise, and the resulting mixture was stirred at 0 ºC under nitrogen for 10 min. Then the residue was quickly purified by flash chromatography on silica gel using CH 2 Cl 2 /CH 3 OH (100/1) as eluent to afford the NML as a blue-violet solid (30 mg, yield 41%). 1 172.79, 160.68, 158.70, 157.63, 153.32, 145.80, 142.10, 141.56, 131.51, 130.80, 129.30, 129.10, 128.53, 127.62, 122.57, 116.46, 115.23, 114.50, 112.84, 109.42, 105.13, 101.55, 71.75, 66.16, 53.49, 50.87, 37.06, 34.85, 29.24, 28.99, 28.03, 24.74, 22.99, 21.91, 20.13 Synthesis of Compound 8. Boc-L-Leucine (1.16 g, 5 mmol) was dissolved in DCM (100 mL), followed by S10 addition of HATU (2.28 g, 6 mmol) and DIPEA (1.65 mL, 10 mmol). After further stirring over 30 min, (4aminophenyl) methanol (1.23 g, 10 mmol) was added, and then the mixture reacted for 12 h at room temperature.
The resultant was washed with water and brine. The organic layer was separated and dried with anhydrous Na 2 SO 4 .
The crude product was purified by silica-gel column chromatography using dichloromethane/methanol (50:1) to 06, 155.89, 138.10, 137.82, 127.33, 119.47, 78.46, 63.08, 54.08, 53.98, 41.22, 28.64, 23.41, 22 .03.
Synthesis of Compound 9. To a solution of compound 8 (840 mg, 2.5 mmol) in CH 2 Cl 2 (50 mL) at 0 °C, tribromophosphine (0.474 mL, 5.0 mmol) was added dropwise. The resulting reaction mixture was warmed up to room temperature and stirred for 5 h. Then, the mixture was diluted with dichloromethane (20 mL), and washed with water and brine. The organic layer was separated and dried with anhydrous Na 2 SO 4 . The solvent was removed by evaporation under reduced pressure, and the obtained crude product 9 was directly used in the following reaction without further purification.
Synthesis of NL.
Compound 6 (462 mg, 1 mmol), compound 9 (798 mg, 2 mmol), NaHCO 3 (168 mg, 2 mmol), 18-crown-6 (264 mg, 1 mmol) and KI (1.66 g, 10 mmol) were mixed in 40 mL acetone, and the resulting mixture was stirred at 40 ºC under nitrogen for 24 h. Then, dichloromethane (50 mL) was added, and the resulting solution was washed water and brine, dried with anhydrous Na 2 SO 4 . After removal of the solvent, the residue was purified by flash chromatography on silica gel using CH 2 Cl 2 /CH 3 OH (200/1~50/1) as eluent to afford the compound 10 as a blue-violet solid. To a solution of compound 10 (100 mg, 0.13 mmol) in CH 2 Cl 2 (2 mL) at 0 °C, a dioxanehydrochloride solution (1 mL, 4 mol/L) was added dropwise, and the resulting mixture was stirred at 0 ºC under nitrogen for 10 min. Then the residue was quickly purified by flash chromatography on silica gel using CH 2 Cl 2 /CH 3 OH (100/1) as eluent to afford the NL as a blue-violet solid (23 mg, yield 26%). 1 88, 169.09, 160.32, 157.46, 153.29, 145.75, 142.26, 137.88, 132.25, 131.07, 130.87, 128.83, 128.43, 127.88, 127.39, 124.88, 122.33, 120.02, 116.71, 114.49, 112.68, 108.56, 104.75, 101.18, 70.93, 52.65, 50.83, 41.03, 31.73, 29.34, 28.78, 26.69, 24.21, 23.65, 21.87, 20.82, 20.14 
Synthesis of Compound 12.
To a solution of compound 11 (702 mg, 2.5 mmol) in CH 2 Cl 2 (50 mL) at 0 °C, tribromophosphine (0.474 mL, 5.0 mmol) was added dropwise. The resulting reaction mixture was warmed up to room temperature and stirred for 5 h. Then, the mixture was diluted with dichloromethane (20 mL), and washed with water and brine. The organic layer was separated and dried with anhydrous Na 2 SO 4 . The solvent was removed by evaporation under reduced pressure, and the obtained crude product 12 was directly used in the following reaction without further purification.
Synthesis of Compound 13. Compound 6 (462 mg, 1 mmol), compound 12 (688 mg, 2 mmol), NaHCO 3 (168 mg, 2 mmol), 18-crown-6 (264 mg, 1 mmol) and KI (1.66 g, 10 mmol) were mixed in 40 mL acetone, and the resulting mixture was stirred at 40 ºC under nitrogen for 24 h. Then, dichloromethane (50 mL) was added, and the resulting solution was washed water and brine, dried with anhydrous Na 2 SO 4 . After removal of the solvent, the residue was 178.79, 160.36, 159.12, 157.58, 153.27, 145.69, 142.27, 142.16, 131.17, 130.81, 128.81, 128.74, 128.30, 128.20, 127.88, 127.36, 122.29, 116.60, 114.46, 114.34, 114.02, 112.64, 108.69, 104.68, 101.23, 78.55, 71.22, 65.34, 50.82, 37.06, 31.84, 29.37, 28.78, 27.37, 26.85, 26.74, 23.71, 20.13 .
Synthesis of NM.
To a solution of compound 13 (100 mg, 0.14 mmol) in CH 2 Cl 2 (2 mL) at 0 °C, a dioxanehydrochloride solution (1 mL, 4 mol/L) was added dropwise, and the resulting mixture was stirred at 0 ºC under nitrogen for 10 min. Then the residue was quickly purified by flash chromatography on silica gel using S12 178.87, 160.31, 158.68, 157.56, 145.70, 142.27, 142.20, 131.10, 130.83, 128.96, 128.81, 128.38, 127.36, 122.30, 116.64, 114.49, 114.37, 112.70, 104.79, 101.19, 71.11, 64.96, 50.82, 37.55, 37.23, 31.83, 28.80, 26.96, 26.67, 23.70, 20.16 λ ex/em = 670/720 nm. S18 Table S2 . The detection limit (3σ/slope) of NML, NM and NL. a. The detection limit is measured under the condition that the MAO concentration is 100 U/L. b. The detection limit is measured under the condition that the LAP concentration is 100 U/L. 
Optical properties and biological studies
MS and NMR spectra
